Theralase Technologies Inc. TLT.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.75M | -2.67M | -2.94M | -3.10M | -3.06M |
| Total Depreciation and Amortization | 180.30K | 188.00K | 190.20K | 187.00K | 189.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 295.10K | 371.40K | 421.00K | 494.60K | 458.20K |
| Change in Net Operating Assets | -175.90K | -186.20K | -32.60K | 597.90K | 78.40K |
| Cash from Operations | -2.45M | -2.29M | -2.36M | -1.82M | -2.33M |
| Capital Expenditure | 15.20K | 10.40K | -33.90K | -69.00K | -64.30K |
| Sale of Property, Plant, and Equipment | 2.70K | 1.50K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 17.90K | 11.90K | -33.90K | -69.00K | -64.30K |
| Total Debt Issued | 375.00K | 375.00K | 375.00K | 100.00K | -- |
| Total Debt Repaid | -101.40K | -102.50K | -100.30K | -111.80K | -106.00K |
| Issuance of Common Stock | 8.31M | 3.76M | 2.98M | 2.40M | 3.04M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.00K | -2.00K | -2.00K | -4.00K | -2.00K |
| Cash from Financing | 6.20M | 2.92M | 2.34M | 1.72M | 2.12M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash | 3.77M | 635.00K | -59.00K | -175.50K | -273.20K |